Trial intelligence / Profile preview

Secretome Injection in ACL Reconstruction

NCT07723625Completed

Sponsor
Prodia Stem Cell Indonesia
Start
Nov 2025
Primary completion
Jan 2026
Countries
1
01

Overview

Randomised, double-blind trial in anterior cruciate ligament injury (2 arms), sponsored by Prodia Stem Cell Indonesia. Primary endpoints: International Knee Documentation Committee Subjective Knee Evaluation Score at 6 months and Tegner-Lysholm Knee Scoring Scale at 6 months. Started Nov 2025; status: completed.

02

Conditions

anterior cruciate ligament injury

Beyond the preview

Go deeper on NCT07723625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07723625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call